Stereotactic Radiosurgery for Cerebral Cavernous Angioma

张南,潘力,戴嘉中,王滨江,王恩敏,蔡佩武

DOI: https://doi.org/10.3969/j.issn.1008-2425.2001.04.007

2001-01-01

Abstract:Objective To evaluate the outcome and benefit of stereotactic radiosurgery (STRS) in cerebral cavernous angioma (CCA). Methods From 1994 to 1995, 57 CCA patients were treated by STRS with a mean peripheral dose of 20.6?Gy (9.0 ～25.2?Gy) and the isodose of 30% ～80%. Magnetic resonance spectroscopy (MRS) was used for differentiation of delayed cerebral necrosis. Results The median follow up duration was (4.38+1.40) years with 4 patients lost . The shrinkage of CCA lesion was demonstrated by radiologic image in 19 patients. Five of 23 patients with history of hemorrhage bled again 4 to 39 months after STRS. Of 25 patients with epilepsy,21(84%) showed alleviation of attacks both in frequency and severity but 6 were unimproved. Four patients with frontal cavernous angioma were cured with suspension of medicine. Seventeen patients with lesion in the frontal parietotemporal lobes developed neurological disability,such as weakness of muscular power and aphasia. Thirty three patients who recieved mannital, corticosteroids and nimotop for cerebral edema for 4 to 14 months showed improvement in the edema. Five resulted in severe neurological deficits and 3 in visual problems. Two received resection after STRS.Conclusions Higher dose (16?Gy) of STRS seems to reduce the incidence of rebleeding after radiosurgery. However,there is no histopathologic evidence of vascular obliteration in the resected CCA specimens after radiosurgery. The benefits and risks must be carefully balanced before the use of radiosurgery for cerebral cavernous hemangioma.